Gene Expression Changes in Colorectal Cancer with KRAS Mutations
Author Information
Author(s): Monticone Massimiliano, Biollo Emanuela, Maffei Massimo, Donadini Alessandra, Romeo Francesco, Storlazzi Clelia Tiziana, Giaretti Walter, Castagnola Patrizio
Primary Institution: Centro Biotecnologie Avanzate, Genova, Italy
Hypothesis
The study investigates how KRAS mutations G12D and G12V affect gene expression in a BRAF mutated colorectal cancer context.
Conclusion
The G12D mutation may be more likely selected in a BRAF mutated context, while the G12V mutation is associated with a more aggressive cancer phenotype.
Supporting Evidence
- KRASG12V mutation deregulated genes related to cell cycle and apoptosis.
- KRASG12D mutation affected genes related to chromatin organization and cell adhesion.
- The presence of KRASG12V may confer a more aggressive cancer phenotype.
Takeaway
This study looks at how two specific changes in a gene called KRAS can change how cancer cells behave, which might help doctors understand and treat colorectal cancer better.
Methodology
The study used a colorectal cancer cell line and performed gene expression profiling through microarray analysis and RT-PCR.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website